MCK logo

McKesson (MCK) Stock

Profile

Full Name:

McKesson Corporation

Sector:

Healthcare

Country:

United States

IPO:

10 November 1994

Indexes:

Description:

McKesson Corporation is a distributor of pharmaceuticals and operator of a pharmacy network. Founded in 1833, the headquarters is located in Irving, Texas. The Pharmaceutical and Specialized Solutions segment in the USA offers branded, generic, specialized, and other healthcare products. The European pharmaceutical segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries. The Medical-Surgical Solutions segment distributes medical-surgical materials and services to healthcare providers in the USA. The Other segment includes McKesson Canada - supplying essential medicines, consumables, and information technology throughout Canada; McKesson Prescription Technology Solutions providing innovative technological solutions to pharmaceutical companies, retail pharmacies, and healthcare systems; and investments in Change Healthcare.

Key Details

Price

$601.90

TTM Dividend Yield

0.44%(-4.35% YoY)

Annual Revenue

$308.95 B(+11.65% YoY)

Annual EPS

$22.39(-10.55% YoY)

PE Ratio

31.17(+35.52% YoY)

Annual ROE

-152.31%

Beta

0.06

Events Calendar

Earnings

Next earnings date:

Feb 05, 2025

Recent quarterly earnings:

Nov 06, 2024

Recent annual earnings:

May 07, 2024
Dividend

Next ex-dividend date:

Mar 03, 2025

Recent ex-dividend date:

Dec 02, 2024
Splits

Next split:

N/A

Recent split:

Jan 05, 1998

Analyst ratings

Recent major analysts updates

10 Jan '25 Citigroup
Buy
06 Jan '25 B of A Securities
Buy
17 Dec '24 Morgan Stanley
Overweight
13 Dec '24 Wells Fargo
Equal-Weight
13 Nov '24 Citigroup
Buy
07 Nov '24 Evercore ISI Group
Outperform
07 Nov '24 Baird
Outperform
07 Oct '24 Leerink Partners
Outperform
25 Sept '24 Deutsche Bank
Buy
24 Sept '24 Baird
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

McKesson (MCK) Declines More Than Market: Some Information for Investors
McKesson (MCK) Declines More Than Market: Some Information for Investors
McKesson (MCK) Declines More Than Market: Some Information for Investors
MCK
zacks.com31 January 2025

At the end of the last trading day, McKesson (MCK) was priced at $594.75, which represents a decrease of 1.63% compared to the day before.

Gear Up for McKesson (MCK) Q3 Earnings: Wall Street Estimates for Key Metrics
Gear Up for McKesson (MCK) Q3 Earnings: Wall Street Estimates for Key Metrics
Gear Up for McKesson (MCK) Q3 Earnings: Wall Street Estimates for Key Metrics
MCK
zacks.com31 January 2025

Assess the anticipated performance of McKesson (MCK) for the quarter that ended in December 2024. Instead of just relying on the usual Wall Street revenue and profit predictions, let's take a closer look at some important metrics for a deeper understanding.

McKesson (MCK) Stock Drops Despite Market Gains: Important Facts to Note
McKesson (MCK) Stock Drops Despite Market Gains: Important Facts to Note
McKesson (MCK) Stock Drops Despite Market Gains: Important Facts to Note
MCK
Zacks29 January 2025

In the most recent trading session, McKesson (MCK) finished at $602.95, which is a decrease of 0.24% compared to the previous day.

McKesson (MCK) Stock Drops Despite Market Gains: Important Facts to Note
McKesson (MCK) Stock Drops Despite Market Gains: Important Facts to Note
McKesson (MCK) Stock Drops Despite Market Gains: Important Facts to Note
MCK
zacks.com28 January 2025

In the most recent trading session, McKesson (MCK) finished at $602.95, which is a decrease of 0.24% compared to the previous day.

McKesson (MCK) Stock Declines While Market Improves: Some Information for Investors
McKesson (MCK) Stock Declines While Market Improves: Some Information for Investors
McKesson (MCK) Stock Declines While Market Improves: Some Information for Investors
MCK
zacks.com21 January 2025

In the most recent trading session, McKesson (MCK) finished at $586.08, which is a decrease of 1.1% compared to the previous day.

Wall Street Analysts Think McKesson (MCK) Is a Good Investment: Is It?
Wall Street Analysts Think McKesson (MCK) Is a Good Investment: Is It?
Wall Street Analysts Think McKesson (MCK) Is a Good Investment: Is It?
MCK
zacks.com21 January 2025

Investors frequently rely on advice from Wall Street analysts when deciding whether to Buy, Sell, or Hold a stock. Although news about changes in ratings from these analysts can influence a stock's price, it's worth questioning their true significance.

McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
MCK
zacks.com21 January 2025

Recently, McKesson (MCK) has caught the interest of users on Zacks.com. It's important to understand the factors that could affect the future of the stock.

MCK Stock Gains 4% in 3 Weeks: Should You Buy, Hold or Sell?
MCK Stock Gains 4% in 3 Weeks: Should You Buy, Hold or Sell?
MCK Stock Gains 4% in 3 Weeks: Should You Buy, Hold or Sell?
MCK
zacks.com21 January 2025

McKesson MCK has begun 2025 well, with its stock rising 4% in January as investors feel hopeful about the company's future. This year's growth is expected to come from its focus on oncology and biopharma services, along with the expansion of The US Oncology Network and the introduction of InspiroGene for cell and gene therapies.

Here's Why McKesson (MCK) is a Strong Value Stock
Here's Why McKesson (MCK) is a Strong Value Stock
Here's Why McKesson (MCK) is a Strong Value Stock
MCK
zacks.com15 January 2025

Are you looking for ways to choose powerful stocks that can outperform the market for your investment portfolio? The Zacks Style Scores can help you with that.

Should Value Investors Buy McKesson (MCK) Stock?
Should Value Investors Buy McKesson (MCK) Stock?
Should Value Investors Buy McKesson (MCK) Stock?
MCK
zacks.com14 January 2025

At Zacks, we concentrate on the reliable Zacks Rank system, which highlights earnings estimates and changes in those estimates to identify excellent stocks. However, we also keep an eye on the most recent trends in value, growth, and momentum to support our top selections.

FAQ

  • What is the primary business of McKesson?
  • What is the ticker symbol for McKesson?
  • Does McKesson pay dividends?
  • What sector is McKesson in?
  • What industry is McKesson in?
  • What country is McKesson based in?
  • When did McKesson go public?
  • Is McKesson in the S&P 500?
  • Is McKesson in the NASDAQ 100?
  • Is McKesson in the Dow Jones?
  • When was McKesson's last earnings report?
  • When does McKesson report earnings?
  • Should I buy McKesson stock now?

What is the primary business of McKesson?

McKesson Corporation is a distributor of pharmaceuticals and operator of a pharmacy network. Founded in 1833, the headquarters is located in Irving, Texas. The Pharmaceutical and Specialized Solutions segment in the USA offers branded, generic, specialized, and other healthcare products. The European pharmaceutical segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries. The Medical-Surgical Solutions segment distributes medical-surgical materials and services to healthcare providers in the USA. The Other segment includes McKesson Canada - supplying essential medicines, consumables, and information technology throughout Canada; McKesson Prescription Technology Solutions providing innovative technological solutions to pharmaceutical companies, retail pharmacies, and healthcare systems; and investments in Change Healthcare.

What is the ticker symbol for McKesson?

The ticker symbol for McKesson is NYSE:MCK

Does McKesson pay dividends?

Yes, McKesson pays dividends. The last payment was $0.71, with an ex-dividend date on 02 December 2024

What sector is McKesson in?

McKesson is in the Healthcare sector

What industry is McKesson in?

McKesson is in the Medical Distribution industry

What country is McKesson based in?

McKesson is headquartered in United States

When did McKesson go public?

McKesson's initial public offering (IPO) was on 10 November 1994

Is McKesson in the S&P 500?

Yes, McKesson is included in the S&P 500 index

Is McKesson in the NASDAQ 100?

No, McKesson is not included in the NASDAQ 100 index

Is McKesson in the Dow Jones?

No, McKesson is not included in the Dow Jones index

When was McKesson's last earnings report?

McKesson's most recent earnings report was on 6 November 2024

When does McKesson report earnings?

The next expected earnings date for McKesson is 5 February 2025

Should I buy McKesson stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions